Revision Bulletin

Oxybutynin Chloride Tablets

In accordance with the Rules and Procedures of the 2005-2010 Council of Experts, the Biopharmaceutics Expert Committee has revised the monograph to include an accepted dissolution test 2 with different dissolution conditions approved by the U.S. Food and Drug Administration.

The Oxybutynin Chloride Tablets Revision Bulletin supersedes the monograph in USP 32-NF 27 until it is printed in the USP 33–NF 28 First Supplement which will be released 1 February 2010 and becomes official 1 August 2010.

Should you have any questions, please contact Margareth Marques, Ph.D., (301–816–8106 or .

Download the Oxybutynin Chloride Tablets Revision Bulletin  (108KB)